Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Convertible Debt (2018 - 2019)

CorMedix's Convertible Debt history spans 2 years, with the latest figure at $6.7 million for Q2 2019.

  • For Q2 2019, Convertible Debt changed N/A year-over-year to $6.7 million; the TTM value through Jun 2019 reached $6.7 million, changed N/A, while the annual FY2018 figure was $6.1 million, N/A changed from the prior year.
  • Convertible Debt for Q2 2019 was $6.7 million at CorMedix, up from $6.4 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $6.7 million in Q2 2019 and bottomed at $6.1 million in Q4 2018.